Markets

Biocon Biologics acquires Viatris's biosimilars biz for $3.33 bn

Pharma

Biocon Biologics, Viatris receive EC nod to market drug for cancer treatment

Industry

Biocon Biologics receives Rs 555 crore Capital Injection from ADQ

Economy

Biocon Biologics signs an MoU with CSSC